For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Astrazeneca plc ADR (NASDAQ: AZN) closed at $66.23 down -2.20% from its previous closing price of $67.72. In other words, the price has decreased by -$2.20 from its previous closing price. On the day, 5.63 million shares were traded. AZN stock price reached its highest trading level at $68.22 during the session, while it also had its lowest trading level at $66.16.
Ratios:
For a deeper understanding of Astrazeneca plc ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 38.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.91. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Exane BNP Paribas on April 15, 2025, initiated with a Outperform rating and assigned the stock a target price of $75.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AZN now has a Market Capitalization of 207931736064 and an Enterprise Value of 129070497792. As of this moment, Astrazeneca’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.61, and their Forward P/E ratio for the next fiscal year is 13.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.38. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 5.00. Its current Enterprise Value per Revenue stands at 2.348 whereas that against EBITDA is 7.062.
Stock Price History:
The Beta on a monthly basis for AZN is 0.37, which has changed by -0.14031672 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, AZN has reached a high of $87.68, while it has fallen to a 52-week low of $61.24. The 50-Day Moving Average of the stock is -7.25%, while the 200-Day Moving Average is calculated to be -9.49%.
Shares Statistics:
For the past three months, AZN has traded an average of 6.11M shares per day and 5398720 over the past ten days. A total of 3.10B shares are outstanding, with a floating share count of 3.10B. Insiders hold about 0.05% of the company’s shares, while institutions hold 16.58% stake in the company. Shares short for AZN as of 1745971200 were 4818500 with a Short Ratio of 0.79, compared to 1743379200 on 10601597. Therefore, it implies a Short% of Shares Outstanding of 4818500 and a Short% of Float of 0.16.
Dividends & Splits
According to the company, the forward annual dividend rate for AZN is 1.55, from 3.1 in the trailing year. Against a Trailing Annual Dividend Yield of 0.045776725The stock’s 5-year Average Dividend Yield is 2.28. The current Payout Ratio is 66.98% for AZN, which recently paid a dividend on 2025-02-21 with an ex-dividend date of 1740096000. Stock splits for the company last occurred on 2015-07-27 when the company split stock in a 2:1 ratio.
